NCT07743723 — Advanced Solid Tumors trial site landscape

Public-registry site landscape for NCT07743723, “A Study of IOV-5001 in Adults With Advanced Solid Tumors”, a Advanced Solid Tumors study sponsored by Iovance Biotherapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07743723 (registry record)
Study title	A Study of IOV-5001 in Adults With Advanced Solid Tumors
Official title	A Phase 1/2, Multicenter, Multi-cohort, Open-label Study of an Autologous Tumor-infiltrating Lymphocytes (TIL) Regimen With IOV-5001 in Participants With Previously Treated Advanced Solid Tumors
Sponsor	Iovance Biotherapeutics, Inc.
Condition(s)	Advanced Solid Tumors; Non-Small Cell Lung Cancer; Triple Negative Breast Cancer (TNBC); Colorectal Cancer
Phase	PHASE1 / PHASE2
Listed sites	0

Patient-friendly overview of this study: eichor.com/study/NCT07743723.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07743723 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →